Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Oct;45(10):793–799. doi: 10.1136/ard.45.10.793

Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

P J Maddison, R P Skinner, R S Pereira, C M Black, B M Ansell, M I Jayson, N R Rowell, K I Welsh
PMCID: PMC1001999  PMID: 3098192

Abstract

The families of 65 patients with systemic sclerosis were examined clinically and serum samples from each subject were tested for antinuclear antibodies (ANA) by immunofluorescence on HEp2 cells and for precipitating antibodies to soluble cellular antigens including Scl-70. Of 217 blood relatives, 58 (27%) had ANA (42 speckled, 13 nucleolar, one centromere, two homogeneous); 22 (10%) had precipitins, one anti-Scl-70, one anti-PM-Scl, one anti-nRNP, two anti-Ro(SSA), the remainder unidentified). Family members tended to share ANA patterns. Of 38 spouses, nine (24%) had ANA (all speckled) and two showed unidentified precipitins. This compares with an incidence of ANA and precipitins in a control population of 8% and 1% respectively. Antibodies were more common in female than male relatives (particularly in mothers and sisters of probands). Twenty one of the 58 family members with ANA had clinical features of connective tissue disease; the remainder were asymptomatic. The presence of genetic factors influencing autoimmunity is suggested by the incidence of autoantibodies in first degree relatives. Similar observations in spouses, however, indicate that environmental factors may also have a role in these immune abnormalities.

Full text

PDF
793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med. 1972 Jan;135(1):68–80. doi: 10.1084/jem.135.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLANCHARD R. E., SPEED E. M. SCLERODERMA: PERIODONTAL MEMBRANE MANIFESTATIONS IN TWO BROTHERS. Periodontics. 1965 Mar-Apr;3:77–80. [PubMed] [Google Scholar]
  3. Black C. M., Welsh K. I., Maddison P. J., Jayson M. I., Bernstein R. M. HLA antigens, autoantibodies and clinical subsets in scleroderma. Br J Rheumatol. 1984 Nov;23(4):267–271. doi: 10.1093/rheumatology/23.4.267. [DOI] [PubMed] [Google Scholar]
  4. Bruun-Petersen G., Lamm L. U., Sørensen I. J., Buskjaer L., Mortensen J. P. Family studies of complement C4 and HLA in man. Hum Genet. 1981;58(3):260–267. doi: 10.1007/BF00294919. [DOI] [PubMed] [Google Scholar]
  5. Burge K. M., Perry H. O., Stickler G. B. "Familial" scleroderma. Arch Dermatol. 1969 Jun;99(6):681–687. [PubMed] [Google Scholar]
  6. Catoggio L. J., Bernstein R. M., Black C. M., Hughes G. R., Maddison P. J. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis. 1983 Feb;42(1):23–27. doi: 10.1136/ard.42.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Christy W. C., Rodnan G. P. Conjugal progressive systemic sclerosis (scleroderma): report of the disease in husband and wife. Arthritis Rheum. 1984 Oct;27(10):1180–1182. doi: 10.1002/art.1780271015. [DOI] [PubMed] [Google Scholar]
  8. Cleland L. G., Bell D. A., Willans M., Saurino B. C. Familial lupus. Family studies of HLA and serologic findings. Arthritis Rheum. 1978 Mar;21(2):183–191. doi: 10.1002/art.1780210202. [DOI] [PubMed] [Google Scholar]
  9. Clements P. J., Opelz G., Terasaki P. I., Mickey M. R., Furst D. Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma). Tissue Antigens. 1978 Apr;11(4):357–361. doi: 10.1111/j.1399-0039.1978.tb01268.x. [DOI] [PubMed] [Google Scholar]
  10. DeHoratius R. J., Pillarisetty R., Messner R. P., Talal N. Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies. J Clin Invest. 1975 Nov;56(5):1149–1154. doi: 10.1172/JCI108190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Douvas A. S., Achten M., Tan E. M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979 Oct 25;254(20):10514–10522. [PubMed] [Google Scholar]
  12. Folomeeva O., Nassonova V. A., Alekberova A. S., Talal N., Williams R. C., Jr Comparative studies of antilymphocyte, antipolynucleotide, and antiviral antibodies among families of patients with systemic lupus erythematosus. Arthritis Rheum. 1978 Jan-Feb;21(1):23–27. doi: 10.1002/art.1780210105. [DOI] [PubMed] [Google Scholar]
  13. Frayha R. A., Tabbara K. F., Geha R. S. Familial CRST syndrome with sicca complex. J Rheumatol. 1977 Spring;4(1):53–58. [PubMed] [Google Scholar]
  14. Gladman D. D., Keystone E. C., Baron M., Lee P., Cane D., Mervert H. Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum. 1981 Jun;24(6):854–856. doi: 10.1002/art.1780240614. [DOI] [PubMed] [Google Scholar]
  15. Gray R. G., Altman R. D. Progressive systemic sclerosis in a family: case report of a mother and son and review of the literature. Arthritis Rheum. 1977 Jan-Feb;20(1):35–41. doi: 10.1002/art.1780200106. [DOI] [PubMed] [Google Scholar]
  16. Greger R. E., Greger R. E. Familial progressive systemic scleroderma. Arch Dermatol. 1975 Jan;111(1):81–85. [PubMed] [Google Scholar]
  17. Haynes D. C., Gershwin M. E. The immunopathology of progressive systemic sclerosis (PSS). Semin Arthritis Rheum. 1982 Feb;11(3):331–351. doi: 10.1016/0049-0172(82)90055-5. [DOI] [PubMed] [Google Scholar]
  18. Kallenberg C. G., Van der Voort-Beelen J. M., D'Amaro J., The T. H. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol. 1981 Mar;43(3):478–485. [PMC free article] [PubMed] [Google Scholar]
  19. Lilis R., Anderson H., Nicholson W. J., Daum S., Fischbein A. S., Selikoff I. J. Prevalence of disease among vinyl chloride and polyvinyl chloride workers. Ann N Y Acad Sci. 1975 Jan 31;246:22–41. doi: 10.1111/j.1749-6632.1975.tb51078.x. [DOI] [PubMed] [Google Scholar]
  20. Lynch C. J., Singh G., Whiteside T. L., Rodnan G. P., Medsger T. A., Jr, Rabin B. S. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol. 1982 Oct;2(4):314–318. doi: 10.1007/BF00915073. [DOI] [PubMed] [Google Scholar]
  21. McAndrew G. M., Barnes E. G. Familial scleroderma. Ann Phys Med. 1965 Nov;8(4):128–131. doi: 10.1093/rheumatology/8.4.128. [DOI] [PubMed] [Google Scholar]
  22. Mund D. J., Greenwald R. A. The CREST syndrome variant of scleroderma in a mother-daughter pair. J Rheumatol. 1978 Fall;5(3):307–310. [PubMed] [Google Scholar]
  23. Reichlin M., Maddison P. J., Targoff I., Bunch T., Arnett F., Sharp G., Treadwell E., Tan E. M. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol. 1984 Jan;4(1):40–44. doi: 10.1007/BF00915286. [DOI] [PubMed] [Google Scholar]
  24. Rendall J. R., McKenzie A. W. Familial scleroderma. Br J Dermatol. 1974 Nov;91(5):517–522. doi: 10.1111/j.1365-2133.1974.tb12939.x. [DOI] [PubMed] [Google Scholar]
  25. Rothfield N. F., Rodnan G. P. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968 Oct;11(5):607–617. doi: 10.1002/art.1780110502. [DOI] [PubMed] [Google Scholar]
  26. Sasaki S., Yoshino H. Systemic scleroderma in mother and daughter. Arch Dermatol. 1977 Mar;113(3):378–379. doi: 10.1001/archderm.1977.01640030124033. [DOI] [PubMed] [Google Scholar]
  27. Sheldon W. B., Lurie D. P., Maricq H. R., Kahaleh M. B., DeLustro F. A., Gibofsky A., LeRoy E. C. Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred. Arthritis Rheum. 1981 May;24(5):668–676. doi: 10.1002/art.1780240507. [DOI] [PubMed] [Google Scholar]
  28. Soppi E., Lehtonen A., Toivanen A. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred. Clin Exp Immunol. 1982 Nov;50(2):275–282. [PMC free article] [PubMed] [Google Scholar]
  29. Strosberg J. M., Peck B., Harris E. D., Jr Scleroderma with intestinal involvement: fatal in two of a kindred. J Rheumatol. 1977 Spring;4(1):46–52. [PubMed] [Google Scholar]
  30. Tabuenca J. M. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet. 1981 Sep 12;2(8246):567–568. doi: 10.1016/s0140-6736(81)90949-1. [DOI] [PubMed] [Google Scholar]
  31. Taj M., Ahmad A. Familial localized scleroderma (morphoea) Arch Dermatol. 1977 Aug;113(8):1132–1133. [PubMed] [Google Scholar]
  32. Takehara K., Moroi Y., Ishibashi Y. Antinuclear antibodies in the relatives of patients with systemic sclerosis. Br J Dermatol. 1985 Jan;112(1):23–33. doi: 10.1111/j.1365-2133.1985.tb02287.x. [DOI] [PubMed] [Google Scholar]
  33. Tan E. M., Rodnan G. P., Garcia I., Moroi Y., Fritzler M. J., Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980 Jun;23(6):617–625. doi: 10.1002/art.1780230602. [DOI] [PubMed] [Google Scholar]
  34. Tuffanelli D. L., McKeon F., Kleinsmith D. M., Burnham T. K., Kirschner M. Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol. 1983 Jul;119(7):560–566. [PubMed] [Google Scholar]
  35. Tuffanelli D. L. Scleroderma, immunological and genetic disease in three families. Dermatologica. 1969;138(2):93–104. doi: 10.1159/000253971. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES